Mylotarg and dyspnoea 
Mylotarg and dyspnoea Patient Reports February 12, 2012
Mylotarg Side Effects Report #4774007-9
Mylotarg side effect was reported by a Consumer or non-health professional from UNITED STATES on Sept 07, 2005. Male patient, 70 years of age, was diagnosed with myelodysplastic syndrome and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, bilirubin conjugated increased, blood alkaline phosphatase increased, blood creatine increased, chest x-ray abnormal, dyspnoea, haemoglobin decreased, haemorrhage. Mylotarg dosage: 7 MG 1X PER 1 DAY, INTRAVENOUS. During the same period patient was treated with ARSENIC TRIOXIDE, PRINIVIL, VITAMINS, TRICOR. Patient was hospitalized. Patient recovered.
Mylotarg Side Effects Report #5105263-5
Mylotarg side effect was reported by a Health Professional from UNITED STATES on Aug 29, 2006. Male patient, 70 years of age, weighting 165.3 lb, was diagnosed with acute myeloid leukaemia recurrent and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: aspartate aminotransferase increased, blood alkaline phosphatase increased, blood lactate dehydrogenase increased, condition aggravated, dyspnoea, infusion related reaction, international normalised ratio increased, pyrexia, thrombocytopenia. Mylotarg dosage: unknown. During the same period patient was treated with NEXIUM, OXYCODONE, NEURONTIN, MORPHINE SULPHATE, AMBIEN, ACETAMINOPHEN. Patient was hospitalized. Patient recovered.
Mylotarg Side Effects Report #4977021-3
Mylotarg side effect was reported by a Physician from UNITED STATES on Mar 30, 2006. Male patient, 70 years of age, weighting 180.2 lb, was diagnosed with acute myeloid leukaemia recurrent and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: aspartate aminotransferase increased, blood alkaline phosphatase increased, blood lactate dehydrogenase increased, chills, condition aggravated, dyspnoea, infusion related reaction, international normalised ratio increased, pyrexia. Mylotarg dosage: 18 MG 1X PER 1 DAY, INTRAVENOUS. During the same period patient was treated with NEXIUM, OXYCODONE, NEURONTIN, MORPHINE SULPHATE, AMBIEN, TYLENOL, ZOSYN. Patient was hospitalized. Patient recovered.
Mylotarg Side Effects Report #5128058-5
Mylotarg side effect was reported by a Consumer or non-health professional from AUSTRALIA on Sept 27, 2006. Male patient, 55 years of age, was diagnosed with acute myeloid leukaemia recurrent and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: bronchospasm, dyspnoea, hypoxia, respiratory disorder, tachycardia, wheezing. Mylotarg dosage: unknown. During the same period patient was treated with MEROPENEM, VORICONAZOLE. Patient recovered.
Mylotarg Side Effects Report #5228511-X
Mylotarg side effect was reported by a Physician from JAPAN on Jan 24, 2007. Male patient, weighting 39.68 lb, was diagnosed with acute myeloid leukaemia recurrent and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: anaemia, dyspnoea, hypoxia, pericardial effusion, tumour lysis syndrome, ventricular dysfunction, ventricular failure. Mylotarg dosage: unknown. During the same period patient was treated with NOVANTRONE, LENOGRASTIM, IDARUBICIN, FRAGMIN, FUTHAN. Patient was hospitalized. Patient died on 03/29/2006.
Mylotarg Side Effects Report #5235843-8
Mylotarg side effect was reported by a Physician from JAPAN on Jan 31, 2007. Male patient, weighting 114.6 lb, was diagnosed with acute myeloid leukaemia recurrent, prophylaxis and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, anaemia, aspartate aminotransferase increased, blood alkaline phosphatase increased, blood bilirubin increased, disease progression, disseminated intravascular coagulation, dyspnoea, fall
. Mylotarg dosage: unknown. During the same period patient was treated with LENDORMIN, ARTIST, TAKEPRON, MUCOSTA. Patient recovered.Mylotarg Side Effects Report #5288523-7
Mylotarg side effect was reported by a Physician from JAPAN on Mar 29, 2007. Male patient, weighting 39.68 lb, was diagnosed with acute myeloid leukaemia recurrent, prophylaxis and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: anaemia, cardiac failure, disseminated intravascular coagulation, dyspnoea, hepatic function abnormal, hypoxia, pericardial effusion, pleural effusion, tumour lysis syndrome. Mylotarg dosage: unknown. During the same period patient was treated with NOVANTRONE, LENOGRASTIM, IDARUBICIN, FRAGMIN. Patient was hospitalized. Patient died on 03/29/2006.
Mylotarg Side Effects Report #4867668-7
Mylotarg side effect was reported by a Consumer or non-health professional from UNITED STATES on Oct 08, 1999. Male patient, 82 years of age, weighting 194.2 lb, was diagnosed with acute myeloid leukaemia and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: bacteraemia, dysphagia, dyspnoea, fungaemia, fungal infection
, mental status changes, pyrexia. Mylotarg dosage: 9 MG/M(2)/CYCLE, INTRAVENOUS. During the same period patient was treated with FLUCONAZOLE. Patient was hospitalized. Patient died on 02/17/1999.Mylotarg Side Effects Report #4949644-9
Mylotarg side effect was reported by a Consumer or non-health professional from UNITED STATES on Mar 08, 2006. Female patient, 77 years of age, weighting 147.2 lb, was diagnosed with acute myeloid leukaemia and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: blood creatinine increased, blood urea increased, cardiomegaly, chills, cough, dyspnoea, fall
, febrile neutropenia, haematocrit decreased. Mylotarg dosage: 15 MG 1X PER 1 DAY, INTRAVENOUS. Patient was hospitalized. Patient recovered.Mylotarg Side Effects Report #4944147-X
Mylotarg side effect was reported by a Consumer or non-health professional from UNITED STATES on Feb 28, 2006. Male patient, 76 years of age, weighting 167.6 lb, was diagnosed with acute myeloid leukaemia, myelodysplastic syndrome and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: blood bicarbonate decreased, blood urea increased, body temperature decreased, bronchoalveolar lavage abnormal, cryptogenic organizing pneumonia, dyspnoea, fungal infection
, granuloma, haematocrit decreased. Mylotarg dosage: 6 MG 1X PER 1 DAY, INTRAVENOUS. During the same period patient was treated with TRISENOX, KEKTOCONAZOLE, ACYCLOVIR, ATENOLOL, SYNTHROID, VITAMINS. Patient was hospitalized. Patient recovered.Mylotarg Side Effects Report #5037506-0
Mylotarg side effect was reported by a Consumer or non-health professional from UNITED STATES on June 09, 2006. Male patient, 76 years of age, weighting 167.6 lb, was diagnosed with acute myeloid leukaemia, myelodysplastic syndrome and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: blood bicarbonate decreased, blood urea increased, body temperature decreased, carbon dioxide decreased, computerised tomogram abnormal, diffuse alveolar damage, dyspnoea, fungal infection
, granuloma. Mylotarg dosage: 6 MG 1X PER 1 DAY, INTRAVENOUS. During the same period patient was treated with TRISENOX, KETOCONAZOLE, ACYCLOVIR, ATENOLOL, SYNTHROID, VITAMINS. Patient was hospitalized. Patient recovered.Mylotarg Side Effects Report #4947095-4
Mylotarg side effect was reported by a Physician from UNITED STATES on Mar 08, 2006. Female patient, 75 years of age, weighting 198.4 lb, was diagnosed with acute myeloid leukaemia and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: cardio-respiratory arrest, dyspnoea, fluid overload, hypoglycaemia, hypotension, hypoxia, infusion related reaction, pyrexia, tachypnoea. Mylotarg dosage: 18 MG ONE TIME PER ONE DOSE; INTRAVENOUS. During the same period patient was treated with INSULIN HUMULIN, LASIX, LOPRESSOR, SYNTHROID, PREMARIN, GLIPIZIDE. Patient died on 05/18/2002.
Mylotarg Side Effects Report #5047652-3
Mylotarg side effect was reported by a Consumer or non-health professional from UNITED STATES on June 29, 2006. Female patient, 73 years of age, weighting 114.6 lb, was diagnosed with acute myeloid leukaemia and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: ascites, blood chloride increased, blood glucose increased, cardiomegaly, catheter related infection, disease progression, dyspnoea, febrile neutropenia, haemoglobin decreased. Mylotarg dosage: 17 MG 1X PER 1 DAY, INTRAVENOUS. During the same period patient was treated with PREDNISONE, PREVACID, SENOKOT, VITAMINS NOS, ZOSYN, DIFLUCAN, LEVAQUIN. Patient was hospitalized. Patient recovered.
Mylotarg Side Effects Report #4802759-8
Mylotarg side effect was reported by a Consumer or non-health professional from UNITED STATES on Oct 03, 2005. Female patient, 73 years of age, weighting 114.6 lb, was diagnosed with acute myeloid leukaemia and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: ascites, blood glucose increased, cardiomegaly, central line infection, chills, disease progression, dyspnoea, febrile neutropenia, haematocrit decreased. Mylotarg dosage: 17 MG 1X PER 1 DAY, INTRAVENOUS. During the same period patient was treated with PREDNISONE, PREVACID, SENOKOT, VITAMINS NOS, ZOSYN, DIFLUCAN, LEVAQUIN. Patient was hospitalized. Patient recovered.
Mylotarg Side Effects Report #4948793-9
Mylotarg side effect was reported by a Consumer or non-health professional from UNITED STATES on Mar 08, 2006. Female patient, 73 years of age, weighting 134.3 lb, was diagnosed with acute myeloid leukaemia and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: chest pain
, deep vein thrombosis , dyspnoea, febrile neutropenia, haemothorax, hypoxia, infusion related reaction, lung infection, pancytopenia. Mylotarg dosage: 10 MG 1X PER 1 DAY, INTRAVENOUS. During the same period patient was treated with CYTARABINE, ALLOPURINOL. Patient was hospitalized. Patient recovered.Mylotarg Side Effects Report #4949574-2
Mylotarg side effect was reported by a Consumer or non-health professional from UNITED STATES on Mar 07, 2006. Female patient, 73 years of age, weighting 114.6 lb, was diagnosed with acute myeloid leukaemia and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: ascites, central line infection, chills, disease progression, dyspnoea, febrile neutropenia, haematocrit decreased, haemoglobin decreased, infusion related reaction. Mylotarg dosage: 17 MG 1X PER 1 DAY, INTRAVENOUS. During the same period patient was treated with PREDNISONE, PREVACID, SENOKOT, VITAMINS NOS, ZOSYN, DIFLUCAN, LEVAQUIN. Patient was hospitalized. Patient recovered.
Mylotarg Side Effects Report #5152761-4
Mylotarg side effect was reported by a Health Professional from UNITED STATES on Nov 02, 2006. Male patient, 72 years of age, weighting 173.3 lb, was diagnosed with acute myeloid leukaemia and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: chills, disease progression, dyspnoea, headache
, hypoaesthesia, infusion related reaction, nausea , pulmonary oedema, pyrexia. Mylotarg dosage: unknown. During the same period patient was treated with CIPRO. Patient died on 03/18/2005.Mylotarg Side Effects Report #4960536-1
Mylotarg side effect was reported by a Health Professional from UNITED STATES on Mar 31, 2006. Female patient, 71 years of age, weighting 192.0 lb, was diagnosed with acute myeloid leukaemia and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: blood bilirubin increased, dyspnoea, weight increased. Mylotarg dosage: unknown. Patient was hospitalized. Patient recovered.
Mylotarg Side Effects Report #4978538-8
Mylotarg side effect was reported by a Consumer or non-health professional from UNITED STATES on Apr 05, 2006. Female patient, 71 years of age, weighting 192.2 lb, was diagnosed with acute myeloid leukaemia and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: blood alkaline phosphatase increased, blood bilirubin increased, disease progression, dyspnoea, weight increased. Mylotarg dosage: unknown. Patient was hospitalized. Patient recovered.
Mylotarg Side Effects Report #5084590-4
Mylotarg side effect was reported by a Consumer or non-health professional from UNITED STATES on Aug 02, 2006. Female patient, 70 years of age, weighting 140.9 lb, was diagnosed with acute myeloid leukaemia and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: bacterial sepsis, disease progression, dyspnoea, febrile neutropenia, haemoglobin decreased, hypotension, staphylococcal infection
, thrombocytopenia. Mylotarg dosage: 16 MG IV EVERY 14 DAYS, INTRAVENOUS. During the same period patient was treated with GLUCOTROL, IMMUNE SERUM GLOBULIN. Patient was hospitalized. Patient died on 04/12/2003.Mylotarg Side Effects Report #5090633-4
Mylotarg side effect was reported by a Consumer or non-health professional from UNITED STATES on Aug 15, 2006. Female patient, 70 years of age, weighting 140.9 lb, was diagnosed with acute myeloid leukaemia and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: anaemia, bacterial sepsis, blood culture positive, dyspnoea, febrile neutropenia, hypotension, malignant neoplasm progression, staphylococcal infection
, thrombocytopenia. Mylotarg dosage: 16 MG IV EVERY 14 DAYS, INTRAVENOUS. During the same period patient was treated with GLUCOTROL, IMMUNE SERUM GLOBULIN. Patient was hospitalized. Patient died on 04/12/2003.Mylotarg Side Effects Report #5096605-8
Mylotarg side effect was reported by a Consumer or non-health professional from UNITED STATES on Aug 21, 2006. Female patient, 70 years of age, weighting 140.9 lb, was diagnosed with acute myeloid leukaemia and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: acute myeloid leukaemia, bacterial sepsis, blood culture positive, disease progression, dyspnoea, febrile neutropenia, hypotension, myelodysplastic syndrome, staphylococcal infection
. Mylotarg dosage: 16 MG IV EVERY 14 DAYS, INTRAVENOUS. During the same period patient was treated with GLUCOTROL, IMMUNE SERUM GLOBULIN. Patient was hospitalized. Patient died on 04/12/2003.Mylotarg Side Effects Report #4616368-7
Mylotarg side effect was reported by a Consumer or non-health professional from on Mar 07, 2005. Male patient, 70 years of age, weighting 180.2 lb, was diagnosed with acute myeloid leukaemia and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: aspartate aminotransferase increased, blood alkaline phosphatase increased, blood lactate dehydrogenase increased, chills, condition aggravated, dyspnoea, pyrexia, thrombocytopenia, weight increased. Mylotarg dosage: unknown. During the same period patient was treated with NEXIUM, OXYCODONE, NEURONTIN, MORPHINE SULPHATE, AMBIEN, TYLENOL, ZOSYN. Patient recovered.
Mylotarg Side Effects Report #4627225-4
Mylotarg side effect was reported by a Consumer or non-health professional from on Mar 18, 2005. Male patient, 70 years of age, weighting 180.2 lb, was diagnosed with acute myeloid leukaemia and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: apnoea, aspartate aminotransferase increased, blood alkaline phosphatase increased, blood bilirubin increased, blood lactate dehydrogenase increased, chills, condition aggravated, dyspnoea, hyperhidrosis. Mylotarg dosage: 18 MG 1X PER 1 DAY, INTRAVENOUS. During the same period patient was treated with NEXIUM, OXYCODONE, NEURONTIN, MORPHINE SULPHATE, AMBIEN, TYLENOL, ZOSYN. Patient was hospitalized. Patient recovered.
Mylotarg Side Effects Report #4631234-9
Mylotarg side effect was reported by a Consumer or non-health professional from on Mar 29, 2005. Male patient, 70 years of age, weighting 180.2 lb, was diagnosed with acute myeloid leukaemia and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: aspartate aminotransferase increased, blood alkaline phosphatase increased, blood lactate dehydrogenase increased, chills, condition aggravated, dyspnoea, hyperhidrosis, international normalised ratio increased, pyrexia. Mylotarg dosage: unknown. During the same period patient was treated with NEXIUM, OXYCODONE, NEURONTIN, AMBIEN, TYLENOL, ZOSYN, GENTAMICIN. Patient was hospitalized. Patient recovered.
Mylotarg Side Effects Report #4949629-2
Mylotarg side effect was reported by a Consumer or non-health professional from UNITED STATES on Mar 08, 2006. Male patient, 70 years of age, weighting 180.2 lb, was diagnosed with acute myeloid leukaemia and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: aspartate aminotransferase increased, blood alkaline phosphatase increased, blood lactate dehydrogenase increased, condition aggravated, dyspnoea, infusion related reaction, thrombocytopenia, weight increased. Mylotarg dosage: unknown. During the same period patient was treated with NEXIUM, OXYCODONE, NEURONTIN, MORPHINE SULPHATE, AMBIEN, ACETAMINOPHEN. Patient was hospitalized. Patient recovered.
Mylotarg Side Effects Report #4986553-3
Mylotarg side effect was reported by a Consumer or non-health professional from UNITED STATES on Apr 11, 2006. Male patient, 70 years of age, weighting 198.4 lb, was diagnosed with acute myeloid leukaemia and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: acute myeloid leukaemia, ascites, chills, disease progression, dizziness
, dyspnoea, febrile neutropenia, fluid overload. Mylotarg dosage: 18.9 MG 1X PER 1 DAY, INTRAVENOUS. Patient was hospitalized. Patient died on 01/08/2006.Mylotarg Side Effects Report #4990373-3
Mylotarg side effect was reported by a Consumer or non-health professional from JAPAN on Apr 14, 2006. Male patient, child 7 years of age, was diagnosed with acute myeloid leukaemia and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: anaemia, chills, disseminated intravascular coagulation, dyspnoea, hepatic function abnormal, hypoxia, neutrophil count decreased, pericardial effusion, platelet count decreased. Mylotarg dosage: 6 MG/M^2 1X PER 1 DAY, INTRAVENOUS DRIP. During the same period patient was treated with CYTARABINE, NOVANTRONE, NEUTROGIN, IDARUBICIN, FRAGMIN, FUTHAN, STRONG NEO MINOPHAGEN C. Patient recovered.
Mylotarg Side Effects Report #4922071-6
Mylotarg side effect was reported by a Consumer or non-health professional from UNITED STATES on Feb 14, 2006. Male patient, 69 years of age, weighting 276.2 lb, was diagnosed with acute myeloid leukaemia and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: blood creatine increased, blood urea increased, chills, dry mouth, dyspnoea, failure to thrive, fatigue, feeling abnormal, headache
. Mylotarg dosage: 21 MG 1X PER 1 DAY, INTRAVENOUS. During the same period patient was treated with DIPHENHYDRAMINE, ACETAMINOPHEN. Patient was hospitalized. Patient died on 05/06/2004.Mylotarg Side Effects Report #4973906-2
Mylotarg side effect was reported by a Consumer or non-health professional from UNITED STATES on Mar 29, 2006. Male patient, 69 years of age, weighting 276.2 lb, was diagnosed with acute myeloid leukaemia and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: ascites, atelectasis, chills, cholelithiasis, dry mouth, dyspnoea, failure to thrive, fatigue, feeling abnormal. Mylotarg dosage: 21 MG 1X PER 1 DAY, INTRAVENOUS. During the same period patient was treated with DIPHENHYDRAMINE, ACETAMINOPHEN. Patient was hospitalized. Patient died on 05/06/2004.
Mylotarg Side Effects Report #4650287-5
Mylotarg side effect was reported by a Physician from on Apr 15, 2005. Male patient, 68 years of age, was diagnosed with acute myeloid leukaemia and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: blood pressure increased, chills, dyspnoea, heart rate increased, infusion related reaction, oxygen saturation decreased. Mylotarg dosage: 18 MG 1X PER 1 DAY, INTRAVENOUS. During the same period patient was treated with DECADRON, DIPHENHYDRAMINE, APAP. Patient recovered.
Mylotarg Side Effects Report #4681377-9
Mylotarg side effect was reported by a Consumer or non-health professional from on May 19, 2005. Female patient, 68 years of age, weighting 161.2 lb, was diagnosed with acute myeloid leukaemia and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: ascites, aspartate aminotransferase increased, bacteraemia, blood alkaline phosphatase increased, blood bilirubin increased, chills, decreased appetite, dyspnoea, enterobacter infection. Mylotarg dosage: 12 MG 1X PER 1 DAY, INTRAVENOUS. During the same period patient was treated with CYTARABINE, ACYCLOVIR, PROTONIX. Patient was hospitalized. Patient recovered.
Mylotarg Side Effects Report #4754314-6
Mylotarg side effect was reported by a Consumer or non-health professional from UNITED STATES on Aug 19, 2005. Female patient, 67 years of age, weighting 117.3 lb, was diagnosed with acute myeloid leukaemia and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: acute myeloid leukaemia, alanine aminotransferase increased, aspartate aminotransferase increased, blood alkaline phosphatase increased, blood bilirubin increased, dyspnoea, hepatotoxicity, malignant neoplasm progression, pleural effusion. Mylotarg dosage: 9.1 MG 1X PER 1 DAY, INTRAVENOUS. Patient was hospitalized. Patient died on 04/03/2004.
Mylotarg Side Effects Report #5097836-3
Mylotarg side effect was reported by a Consumer or non-health professional from UNITED STATES on Aug 24, 2006. Female patient, 66 years of age, weighting 106.5 lb, was diagnosed with acute myeloid leukaemia and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: acute myeloid leukaemia, condition aggravated, culture urine positive, dyspnoea, enterococcal infection, haemoptysis, hydropneumothorax, leukaemia cutis, malignant neoplasm progression. Mylotarg dosage: unknown. Patient was hospitalized. Patient died on 12/03/2003.
Mylotarg Side Effects Report #5051531-5
Mylotarg side effect was reported by a Health Professional from UNITED STATES on June 28, 2006. Male patient, 65 years of age, was diagnosed with acute myeloid leukaemia and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: disease progression, dyspnoea, liver function test abnormal, oedema. Mylotarg dosage: 12 MG 1X PER 1 DAY, INTRAVNEOUS. Patient died on 02/16/2006.
Mylotarg Side Effects Report #4556856-5
Mylotarg side effect was reported by a Consumer or non-health professional from on Jan 06, 2005. Male patient, 65 years of age, weighting 188.5 lb, was diagnosed with acute myeloid leukaemia and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: blood albumin decreased, blood chloride increased, chills, dyspnoea, haemoglobin decreased, platelet count decreased, stridor, wheezing, white blood cell count decreased. Mylotarg dosage: 18.6 MG 1X PER 1 DAY, INTRAVENOUS. During the same period patient was treated with BENADRYL, HYDROCORTISONE. Patient was hospitalized. Patient recovered.
Mylotarg Side Effects Report #4587995-0
Mylotarg side effect was reported by a Consumer or non-health professional from on Feb 02, 2005. Male patient, 65 years of age, weighting 188.5 lb, was diagnosed with acute myeloid leukaemia and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: blood albumin decreased, blood chloride increased, chills, dyspnoea, haemoglobin decreased, platelet count decreased, stridor, wheezing, white blood cell count decreased. Mylotarg dosage: 18.6 MG 1X PER 1 DAY, INTRAVENOUS. Patient was hospitalized. Patient recovered.
Mylotarg Side Effects Report #4949075-1
Mylotarg side effect was reported by a Consumer or non-health professional from UNITED STATES on Mar 08, 2006. Male patient, 65 years of age, weighting 188.5 lb, was diagnosed with acute myeloid leukaemia and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: blood albumin decreased, blood chloride increased, chills, dyspnoea, haemoglobin decreased, infusion related reaction, platelet count decreased, stridor, weight increased. Mylotarg dosage: 18.6 MG 1X PER 1 DAY, INTRAVENOUS. Patient was hospitalized. Patient recovered.
Mylotarg Side Effects Report #4961840-3
Mylotarg side effect was reported by a Consumer or non-health professional from UNITED STATES on Mar 17, 2006. Male patient, 65 years of age, weighting 188.5 lb, was diagnosed with acute myeloid leukaemia and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: blood albumin decreased, blood alkaline phosphatase increased, blood chloride increased, chills, dyspnoea, haemoglobin decreased, infusion related reaction, platelet count decreased, stridor. Mylotarg dosage: 18.6 MG 1X PER 1 DAY, INTRAVENOUS. Patient was hospitalized. Patient recovered.
Mylotarg Side Effects Report #4948796-4
Mylotarg side effect was reported by a Consumer or non-health professional from UNITED STATES on Mar 08, 2006. Male patient, 64 years of age, weighting 145.5 lb, was diagnosed with acute myeloid leukaemia and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: chest discomfort, dyspnoea, hyperhidrosis, hypotension, hypoxia, infusion related reaction. Mylotarg dosage: 11 MG 1X PER 1 DAY, INTRAVENOUS. During the same period patient was treated with CYTARABINE, ZOFRAN, PROPRANOLOL, ENALAPRIL MALEATE, ACYCLOVIR, PREVACID, PHOSLO, ITRACONAZONE. Patient recovered.
Mylotarg Side Effects Report #4953648-X
Mylotarg side effect was reported by a Consumer or non-health professional from UNITED STATES on Mar 08, 2006. Male patient, 64 years of age, weighting 164.2 lb, was diagnosed with acute myeloid leukaemia and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: acute myeloid leukaemia, chills, dyspnoea, hypotension, infusion related reaction, malignant neoplasm progression, oxygen saturation decreased, pyrexia, tachycardia. Mylotarg dosage: 17 MG 1X PER 1 DAY, INTRAVENOUS. During the same period patient was treated with ALLOPURINOL, DIPHENHYDRAMINE, PERCOCET, RESTORIL, ATIVAN. Patient died on 07/31/2003.
Mylotarg Side Effects Report #5105193-9
Mylotarg side effect was reported by a Consumer or non-health professional from UNITED STATES on Aug 29, 2006. Male patient, 62 years of age, weighting 160.3 lb, was diagnosed with acute myeloid leukaemia and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: bilirubin conjugated increased, blood bilirubin increased, blood calcium decreased, carbon dioxide decreased, disease progression, dyspnoea, fluid overload, hypovolaemia. Mylotarg dosage: A SINGLE 10 MG, DOSE, INTRAVENOUS; 11 MG, INTRAVENOUS. During the same period patient was treated with CYTARABINE, ETOPOSIDE, NOVANTRONE, PANTOPRAZOLE, ACYCLOVIR, ACETAMINOPHEN, DIPHENHYDRAMINE, LORAZEPAM. Patient died on 12/29/2004.
Mylotarg Side Effects Report #4951677-3
Mylotarg side effect was reported by a Consumer or non-health professional from UNITED STATES on Mar 08, 2006. Male patient, 62 years of age, weighting 198.6 lb, was diagnosed with acute myeloid leukaemia and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, blood alkaline phosphatase increased, blood bilirubin increased, chills, dyspnoea, infusion related reaction, pyrexia, weight increased. Mylotarg dosage: 18 MG 1X PER 1 DAY, INTRAVENOUS. Patient recovered.
Mylotarg Side Effects Report #5119438-2
Mylotarg side effect was reported by a Consumer or non-health professional from UNITED STATES on Sept 19, 2006. Male patient, 61 years of age, was diagnosed with acute myeloid leukaemia and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: blood gases abnormal, body temperature increased, dyspnoea, haemoptysis, heart rate increased, pulmonary alveolar haemorrhage, respiratory failure, tachycardia, tachypnoea. Mylotarg dosage: 11 MG 1X PER 1 DAY, INTRAVENOUS. Patient was hospitalized. Patient recovered.
Mylotarg Side Effects Report #4658365-1
Mylotarg side effect was reported by a Consumer or non-health professional from on Apr 26, 2005. Male patient, 61 years of age, weighting 186.1 lb, was diagnosed with acute myeloid leukaemia and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: blood bilirubin increased, blood culture positive, catheter related infection, chills, dyspnoea, epistaxis, fatigue, febrile neutropenia, haematocrit decreased. Mylotarg dosage: 18 MG 1X PER 1 DAY, INTRAVENOUS. Patient was hospitalized. Patient recovered.
Mylotarg Side Effects Report #4867680-8
Mylotarg side effect was reported by a Consumer or non-health professional from UNITED STATES on Apr 13, 2002. Female patient, 60 years of age, was diagnosed with acute myeloid leukaemia and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: dyspnoea, hypotension, hypoxia, pyrexia. Mylotarg dosage: 9 MG/M 2, INTRAVENOUS. Patient was hospitalized. Patient recovered.
Mylotarg Side Effects Report #4949643-7
Mylotarg side effect was reported by a Consumer or non-health professional from UNITED STATES on Mar 08, 2006. Male patient, 60 years of age, weighting 186.1 lb, was diagnosed with acute myeloid leukaemia and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: blood bilirubin increased, catheter related infection, chills, dyspnoea, epistaxis, fatigue, febrile neutropenia, haematocrit decreased, haemoglobin decreased. Mylotarg dosage: 18 MG 1X PER 1 DAY, INTRAVENOUS. Patient was hospitalized. Patient recovered.
Mylotarg Side Effects Report #4627236-9
Mylotarg side effect was reported by a Pharmacist from on Apr 01, 2005. Female patient, 55 years of age, weighting 167.6 lb, was diagnosed with acute myeloid leukaemia and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: dyspnoea, hypotension. Mylotarg dosage: 17 MG OVER 2 HOURS INTRAVENOUS. During the same period patient was treated with GATIFLOXACIN, FLUCONAZOLE, ACYCLOVIR, PANTOPRAZOLE, CHLORHEXIDIN, URSIDIOL, DAPTOMYCIN. Patient recovered.
Mylotarg Side Effects Report #5055471-7
Mylotarg side effect was reported by a Consumer or non-health professional from UNITED STATES on June 30, 2006. Female patient, 53 years of age, weighting 194.2 lb, was diagnosed with acute myeloid leukaemia and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: candidiasis, dyspnoea, febrile neutropenia, hypoxia, lung neoplasm, white blood cell count decreased. Mylotarg dosage: 11.6 MG 1X PER 1 DAY, INTRAVENOUS. Patient was hospitalized. Patient recovered.
Mylotarg Side Effects Report #4744076-0
Mylotarg side effect was reported by a Physician from UNITED STATES on Aug 01, 2005. Female patient, 53 years of age, weighting 194.2 lb, was diagnosed with acute myeloid leukaemia and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: candidiasis, dyspnoea, febrile neutropenia, hypoxia, lung neoplasm. Mylotarg dosage: 11.6 MG 1X PER 1 DAY, INTRAVENOUS. Patient was hospitalized. Patient recovered.
Mylotarg Side Effects Report #4867676-6
Mylotarg side effect was reported by a Consumer or non-health professional from UNITED STATES on Sept 28, 1999. Male patient, 53 years of age, was diagnosed with acute myeloid leukaemia and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: aspergillosis, catheter related infection, dyspnoea, fungal infection
, headache , meningitis , neutropenia, oxygen saturation decreased. Mylotarg dosage: 9 MG/M2, INTRAVENOUS. Patient was hospitalized. Patient died on 07/19/1999.Mylotarg Side Effects Report #5041731-2
Mylotarg side effect was reported by a Consumer or non-health professional from UNITED STATES on June 20, 2006. Female patient, 53 years of age, weighting 194.2 lb, was diagnosed with acute myeloid leukaemia and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: candidiasis, dyspnoea, febrile neutropenia, hypoxia, lung neoplasm. Mylotarg dosage: 11.6 MG 1X PER 1 DAY, INTRAVENOUS. Patient was hospitalized. Patient recovered.
Mylotarg Side Effects Report #5041835-4
Mylotarg side effect was reported by a Consumer or non-health professional from UNITED STATES on June 19, 2006. Female patient, 51 years of age, weighting 106.9 lb, was diagnosed with acute myeloid leukaemia and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: abdominal distension, alanine aminotransferase increased, aspartate aminotransferase increased, atelectasis, blood alkaline phosphatase increased, blood lactate dehydrogenase increased, diarrhoea, dyspnoea, haemangioma of liver. Mylotarg dosage: 13 MG 1X PER 1 DAY, INTRAVENOUS. During the same period patient was treated with ZYPREXA, ZOLOFT, ACYCLOVIR, DIFLUCAN, LEVAQUIN, PROGRAF, CYTARABINE. Patient was hospitalized. Patient recovered.
Mylotarg Side Effects Report #5147885-1
Mylotarg side effect was reported by a Consumer or non-health professional from UNITED STATES on Oct 25, 2006. Female patient, 45 years of age, weighting 119.6 lb, was diagnosed with acute myeloid leukaemia and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: ascites, aspartate aminotransferase increased, atelectasis, caecitis, clostridium difficile colitis, constipation
, dyspnoea, hypocalcaemia, hypoglycaemia. Mylotarg dosage: 6 MG/M^2 1X PER 1 DAY, INTRAVENOUS. During the same period patient was treated with CYTARABINE, DAUNORUBICIN. Patient was hospitalized. Patient recovered.Mylotarg Side Effects Report #4911625-9
Mylotarg side effect was reported by a Consumer or non-health professional from UNITED STATES on Jan 30, 2006. Male patient, 44 years of age, weighting 203.7 lb, was diagnosed with acute myeloid leukaemia and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: aspartate aminotransferase increased, blood alkaline phosphatase increased, dyspnoea, hyperglycaemia, hypotension, infusion related reaction, pyrexia, tachycardia, weight increased. Mylotarg dosage: unknown. Patient recovered.
Mylotarg Side Effects Report #4920772-7
Mylotarg side effect was reported by a Consumer or non-health professional from UNITED STATES on Feb 07, 2006. Male patient, 44 years of age, weighting 203.7 lb, was diagnosed with acute myeloid leukaemia and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: aspartate aminotransferase increased, blood alkaline phosphatase increased, dyspnoea, hyperglycaemia, hypotension, infusion related reaction, pyrexia, tachycardia, weight increased. Mylotarg dosage: 13 MG 1X PER 1 DAY, INTRAVENOUS; 8.8 MG 1X PER 1 DAY, INTRAVENOUS. Patient recovered.
Mylotarg Side Effects Report #4937484-6
Mylotarg side effect was reported by a Consumer or non-health professional from UNITED STATES on Feb 22, 2006. Male patient, 44 years of age, weighting 203.7 lb, was diagnosed with acute myeloid leukaemia and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: aspartate aminotransferase increased, blood alkaline phosphatase increased, dyspnoea, hyperglycaemia, hypotension, infusion related reaction, pyrexia, tachycardia, weight increased. Mylotarg dosage: 13 MG 1X PER 1 DAY, INTRAVENOUS; 8.8 MG 1X PER 1 DAY, INTRAVENOUS. During the same period patient was treated with METHYLPREDNISOLONE. Patient recovered.
Mylotarg Side Effects Report #4952400-9
Mylotarg side effect was reported by a Consumer or non-health professional from UNITED STATES on Mar 08, 2006. Male patient, 44 years of age, weighting 203.7 lb, was diagnosed with acute myeloid leukaemia and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: aspartate aminotransferase increased, blood alkaline phosphatase increased, cryptogenic organizing pneumonia, dyspnoea, hyperglycaemia, hypotension, infusion related reaction, tachycardia, weight increased. Mylotarg dosage: 13 MG 1X PER 1 DAY, INTRAVENOUS; 8.8 MG 1X PER 1 DAY, INTRAVENOUS. During the same period patient was treated with METHYLPREDNISOLONE. Patient recovered.
Mylotarg Side Effects Report #4869962-2
Mylotarg side effect was reported by a Consumer or non-health professional from UNITED STATES on Dec 13, 2005. Male patient, 36 years of age, was diagnosed with acute myeloid leukaemia and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: blood creatinine increased, blood urea increased, cardio-respiratory arrest, dyspnoea, epistaxis, febrile neutropenia, haematuria, hypotension, infection
. Mylotarg dosage: 6 MG/M^2 1X PER 1 DOS, INTRAVENOUS. During the same period patient was treated with CYTARABINE. Patient died on 11/22/2000.Mylotarg Side Effects Report #4948795-2
Mylotarg side effect was reported by a Consumer or non-health professional from UNITED STATES on Mar 08, 2006. Male patient, 34 years of age, weighting 194.7 lb, was diagnosed with acute myeloid leukaemia and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: abdominal pain
, blast cells present, chills, condition aggravated, diarrhoea, dyspnoea, haematocrit decreased, haemoglobin decreased, hypotension. Mylotarg dosage: 18 MG 1X PER 1 DAY, INTRAVENOUS. Patient was hospitalized. Patient recovered.Mylotarg Side Effects Report #4908980-2
Mylotarg side effect was reported by a Consumer or non-health professional from UNITED STATES on Dec 01, 2003. Female patient, 19 years of age, was diagnosed with acute myeloid leukaemia and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: abdominal pain upper, anorexia, aspartate aminotransferase increased, blood bilirubin increased, conjunctival haemorrhage, disseminated intravascular coagulation, dyspnoea, febrile neutropenia, fluid overload. Mylotarg dosage: 18.6 MG ONE TIME PER ONE DOSE, INTRAVENOUS. During the same period patient was treated with CYTARABINE, DAUNORUBICIN. Patient was hospitalized. Patient recovered.
Mylotarg Side Effects Report #4655982-X
Mylotarg side effect was reported by a Health Professional from on May 06, 2005. Male patient, 15 years of age, weighting 112.0 lb, was diagnosed with acute myeloid leukaemia and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: acute myeloid leukaemia, acute respiratory distress syndrome, arrhythmia
, blood pressure decreased, bone marrow disorder, central line infection, dyspnoea, malignant neoplasm progression, malignant pleural effusion. Mylotarg dosage: 12.5 MG, 1 DOSE, INFUSION LINE. During the same period patient was treated with CYTARABINE, IMMUNE GLOBULIN, LIPOSOMAL AMPHOTERICIN, VORICONAZOLE. Patient died on 04/11/2005.Mylotarg Side Effects Report #5315462-5
Mylotarg side effect was reported by a Health Professional from UNITED STATES on Apr 25, 2007. Female patient, weighting 200.2 lb, was diagnosed with acute myeloid leukaemia, deep vein thrombosis
and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: dyspnoea, pleural effusion, pulmonary oedema. Mylotarg dosage: unknown. During the same period patient was treated with COUMADIN. Patient recovered.Mylotarg Side Effects Report #5141357-6
Mylotarg side effect was reported by a Consumer or non-health professional from UNITED STATES on Oct 30, 2006. Female patient, weighting 119.6 lb, was diagnosed with acute myeloid leukaemia and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: ascites, aspartate aminotransferase increased, atelectasis, caecitis, clostridial infection, constipation
, dyspnoea, hyperglycaemia, hypocalcaemia. Mylotarg dosage: 9.5 MG. During the same period patient was treated with CYTARABINE, DAUNORUBICIN. Patient was hospitalized. Patient recovered.